Clinical trials—the complex, lengthy process of testing new medicines—are facing a fundamental transformation, driven less by new drugs themselves and more by powerful, foundational technology. According to industry experts, the framework of future clinical trials will rely on artificial intelligence (AI) and blockchain technology to an extent previously unseen

The race to develop effective treatments for Alzheimer's disease (AD) is one of the most critical challenges facing modern medicine, but clinical trials for AD therapies face enormous hurdles

Imagine taking a pill hoping it will make you feel better, but instead, it does nothing, or worse, makes you sicker. This terrifying scenario is the grim reality for millions around the world, victims of a rampant and insidious problem: counterfeit drugs.